JPMorgan increases its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.02 per share.
On September 11, JPMorgan increased its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.0248 per share, for a total amount of approximately HK$535 million.
The latest information from the Hong Kong Stock Exchange shows that on September 11, JPMorgan increased its shareholding in GENSCRIPT BIO (01548) by approximately 16.7171 million shares at approximately HK$32.0248 per share, for a total amount of approximately HK$535 million. After the increase, its latest shareholding is approximately 165 million shares, with its latest shareholding percentage at 7.48%.
Related Articles
Huatai (06886): "23 Huatai 11" will have its principal and interest paid and be delisted on September 21.
KIMOU ENVIRON (06805) repurchased 350,000 shares for HK$1.0435 million on September 16.
Zhejiang Kaier New Materials (300234.SZ)'s controlling shareholder and its concert parties plan to transfer 10.3% of the company's shares to Luzhou Jinkai.
Huatai (06886): "23 Huatai 11" will have its principal and interest paid and be delisted on September 21.
KIMOU ENVIRON (06805) repurchased 350,000 shares for HK$1.0435 million on September 16.
Zhejiang Kaier New Materials (300234.SZ)'s controlling shareholder and its concert parties plan to transfer 10.3% of the company's shares to Luzhou Jinkai.
RECOMMEND
